Grifols, S.A.
Grifols, S.A. (GRFS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GRFS · as of Sep 30, 2025
Ownership Breakdown
184
Institutional Holders
▲ 25 vs Q2
$1.40B
Total Inst. Value
▲ $78.38M vs Q2
845.97M
Shares Outstanding
freeFloat 99.94%
140.20M
13F Shares Held
▼ 5.55M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GRFS largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BRANDES INVESTMENT PARTNERS, LP pharmaceutical preparations | 29.12M | 4.23% | 4.23% | $289.99B | Nov 14, 2025 | ▲ 1.08M |
CAPITAL WORLD INVESTORS pharmaceutical preparations | 22.93M | 3.33% | 3.33% | $228.34B | Nov 13, 2025 | ▲ 1.27M |
PERMIAN INVESTMENT PARTNERS, LP pharmaceutical preparations | 17.45M | 2.53% | 2.53% | $173.83B | Nov 14, 2025 | ▼ 1.18M |
BLACK CREEK INVESTMENT MANAGEMENT INC. pharmaceutical preparations | 10.05M | 1.46% | 1.46% | $100.06B | Nov 12, 2025 | ▼ 2.52M |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 6.94M | 1.01% | 1.01% | $69.10B | Nov 14, 2025 | ▼ 2.73M |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 3.99M | 57.98% | 57.98% | $39.77B | Feb 3, 2026 | ▲ 975.1K |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 3.45M | 50.10% | 50.10% | $34.33B | Nov 14, 2025 | ▲ 250.2K |
BANK OF MONTREAL /CAN/ pharmaceutical preparations | 3.01M | 43.77% | 43.77% | $30.02B | Nov 13, 2025 | ▲ 2.92M |
MORGAN STANLEY pharmaceutical preparations | 2.99M | 43.47% | 43.47% | $29.82B | May 27, 2026 | ▲ 1.08M |
UBS GROUP AG pharmaceutical preparations | 2.80M | 40.73% | 40.73% | $27.93B | Nov 13, 2025 | ▲ 595.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
26
Increased
+13.19M shares3
New Positions
first time holders14
Decreased
−16.69M shares0
Sold Out
fully exitedNet shares change (top 50)
3.50M
+13.19M / −16.69M
Net new holders
+15
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GRFS insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Grifols, S.A. (GRFS) is primarily owned by institutional investors, who hold approximately 16.6% of total shares outstanding. Company insiders own approximately 0.06%, while retail and public investors account for the remaining 83.37%.
The largest institutional shareholder of Grifols, S.A. is BRANDES INVESTMENT PARTNERS, LP, holding approximately 29.12 million shares — equal to 4.23% of outstanding shares — as of September 30, 2025.
A total of 184 institutional investors currently hold GRFS stock, with a combined institutional value of approximately $1.40 billion as of the most recent 13F filing period.
Frequently asked questions
GRFS ownershipGrifols, S.A. (GRFS) is primarily owned by institutional investors, who hold approximately 16.6% of shares. The largest shareholder is BRANDES INVESTMENT PARTNERS, LP with a 4.23% stake. Company insiders hold 0.06%. Data sourced from SEC Form 13F as of September 30, 2025.